Home Page

A few months ago an article was published in JAMA asking the question “Why are Legionnaires Disease Diagnoses becoming More Common in the US?” In this installment, Dr. Daly discusses the several interesting are...

One of the major areas reviewed during an audit of a laboratory performing urine drug screening is documentation of medical necessity of the testing. In this installment, Dr. Daly discusses the criteria to esta...

In drug testing of pain management patients, it is important that a valid sample is collected in order to determine compliance with appropriate use of prescribed drugs and to identify the use of other non-presc...

It is estimated that more than 4 million individuals have been infected with the Hepatitis C Virus (HCV) in the U.S., and from that number, some 75% are infected at any given time. In the latest installment of ...

At the recent Executive War College presented by the Dark Intelligence Group, there was a roundtable presentation featuring four attorneys active in laboratory legal affairs discussing “Current Issues in Clinic...

Insurers and the government are scrutinizing laboratory billing arrangements where small, financially challenged hospitals contract with Medical Service Organizations (MSO) to perform laboratory marketing servi...

Clinical laboratories large and small are experiencing increased scrutiny from the federal government, states and private insurers.  This focus has developed because payers have identified several areas in whic...